Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
Surgeon general nominee Casey Means postpones confirmation hearing due to going into labor, prolonging vacancy in top public health post.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
Surgeon general nominee Casey Means postpones confirmation hearing due to going into labor, prolonging vacancy in top public health post.